Serial Prostate Biopsies are Associated With an Increased Risk of Erectile Dysfunction in Men With Prostate Cancer on Active Surveillance

Journal of Urology

Volumn 182, Issue 6, 2009, Pages 2664-2669

  Fujita, Kazutoshi ^a   Landis, Patricia ^a   McNeil, Brian K ^a   Pavlovich, Christian P ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

biopsy; erectile dysfunction; needle; prostatic neoplasms; prostatism

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; ERECTILE DYSFUNCTION; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; SEXUAL HEALTH;

AGED; BIOPSY, NEEDLE; ERECTILE DYSFUNCTION; HUMANS; MALE; POPULATION SURVEILLANCE; PROSTATIC NEOPLASMS; PROSTATISM; QUESTIONNAIRES; RISK;

EID: 71849088389     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.08.044     Document Type: Article

References (23)

1. Djavan B., Waldert M., Zlotta A., et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 166 (2001) 856
2. Raaijmakers R., Kirkels W.J., Roobol M.J., et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60 (2002) 826
3. Akbal C., Turker P., Tavukcu H.H., et al. Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy. Eur Urol 53 (2008) 540
4. Chrisofos M., Papatsoris A.G., Dellis A., et al. Can prostate biopsies affect erectile function?. Andrologia 38 (2006) 79
5. Zisman A., Leibovici D., Kleinmann J., et al. The impact of prostate biopsy on patient well-being: a prospective study of voiding impairment. J Urol 166 (2001) 2242
6. Zisman A., Leibovici D., Kleinmann J., et al. The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol 165 (2001) 445
7. Coogan C.L., Latchamsetty K.C., Greenfield J., et al. Increasing the number of biopsy cores improves the concordance of biopsy Gleason score to prostatectomy Gleason score. BJU Int 96 (2005) 324
8. Presti Jr. J.C., O'Dowd G.J., Miller M.C., et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 169 (2003) 125
9. Scattoni V., Zlotta A., Montironi R., et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 52 (2007) 1309
10. Dall'Era M.A., Konety B.R., Cowan J.E., et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112 (2008) 2664
11. Hardie C., Parker C., Norman A., et al. Early outcomes of active surveillance for localized prostate cancer. BJU Int 95 (2005) 956
12. Klotz L. Active surveillance with selective delayed intervention: using natural history to guide treatment in good risk prostate cancer. J Urol 172 (2004) S48
13. Warlick C.A., Allaf M.E., and Carter H.B. Expectant treatment with curative intent in the prostate-specific antigen era: triggers for definitive therapy. Urol Oncol 24 (2006) 51
14. Carter H.B., Landis P.K., Epstein J.I., et al. Expectant management of prostate cancer with curative intent. Eur Urol 39 (2001) 24
15. Cappelleri J.C., Siegel R.L., Glasser D.B., et al. Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. Clin Ther 23 (2001) 1707
16. Rosen R.C., Cappelleri J.C., Smith M.D., et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11 (1999) 319
17. Barry M.J., Fowler Jr. F.J., O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148 (1992) 1549
18. Djavan B., Ravery V., Zlotta A., et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?. J Urol 166 (2001) 1679
19. Freedland S.J., Kane C.J., Amling C.L., et al. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology 69 (2007) 495
20. Tuncel A., Kirilmaz U., Nalcacioglu V., et al. The impact of transrectal prostate needle biopsy on sexuality in men and their female partners. Urology 71 (2008) 1128
21. Sakr W.A., Grignon D.J., Crissman J.D., et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 8 (1994) 439
22. Johannes C.B., Araujo A.B., Feldman H.A., et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 163 (2000) 460
23. Meigs J.B., Mohr B., Barry M.J., et al. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54 (2001) 935